Zinc Investment Management LLP is a UK venture capital investor in deep tech companies in health, life sciences and environmental technologies. Zinc invests at the earliest stages, turning cutting-edge UK science into globally ambitious commercial companies.
In health, Zinc invests in engineering biology, medical devices, therapeutics, clinical services and enabling technologies in life sciences. In environmental technologies, Zinc invests in clean energy, materials innovation, food & agriculture, and climate adaptation.
With its first £30m Fund, Zinc has built a diversified portfolio of over 40 companies across health and environment, including spin-outs from top universities and backing serial entrepreneurs with their own IP assets.
As well as capital, Zinc provides a high-level of hands-on, value-add support to founders across the first two years of the new companies they are building. This support includes technical development, building the company, hiring, securing funding, IP protection and regulation, and go-to-market.
Reason for commitment from British Business Bank
The Bank previously made a commitment to Zinc II in 2022. Zinc’s Science-For-Impact Fund builds on Zinc’s position in the UK VC ecosystem, attracting a diverse and technical founder base at the company creation stage and early-stage investment in the UK.
This aligns closely with the Bank’s objective of strengthening the pipeline of new and investable companies and strategy to support the UK’s most promising companies in the Industrial Strategy sectors of Advanced Manufacturing, Clean Energy and Life Sciences.
Previous investments by the manager
- Spine
- Signacor
- Epiome
- Cellmine
- Unravel
- CamMed
- Cordon
- Speek
Zinc Science-For-Impact Fund has completed full British Business Bank due diligence and received Investment Committee approval.
This is an investment under the Enterprise Capital Funds programme, through which the British Business Bank takes a reduced profit share. Once original commitments have been repaid, the British Business Bank does not take its pro rata share of profits, with additional returns flowing to private investors.
The level of public leverage and profit share is set through a competitive process to ensure the British Business Bank receives a commercially viable return while providing sufficient incentive for private investors to commit capital to venture funds.
-
Fund Manager
Zinc Investment Management LLP
-
Based in
London, UK
-
Stage
Early stage
-
Industrial Strategy Sectors
Advanced Manufacturing, Clean Energy, Life Sciences
-
Structure
GP/LP
-
Fundraising target
£70 million
-
British Business Bank Commitment
Up to £46 million
Disclaimer
This website includes information about UK investment funds in which one or more entities within the British Business Bank group (“BBB Group”) may be investors. This information is provided for information purposes only – it has no regard to the specific investment objectives or particular needs of any person and does not constitute an offer, recommendation, or financial promotion under applicable legislation. The BBB Group does not market or make investment opportunities available to the public. Fund details are provided by external sources and the BBB Group does not verify their accuracy. Fund investments involve significant risk, including the risk of losing capital.
Access to this website is intended for authorised persons only. Users are responsible for complying with local laws and regulations regarding access. Any investment enquiries must be directed to the relevant fund manager and any investment decisions must be based solely on information provided by the relevant fund or fund manager.
